CNS Lymphoma Market: By Prognosis Type; By Diagnosis Type; By Types of Treatments (Radiation Therapy, Chemotherapy, Steroid Therapy, High-dose chemotherapy with stem cell transplant); By Geography - Analysis & Forecast (2016-2021)

  • ID: 3919998
  • Report
  • 153 pages
  • IndustryARC
1 of 3
Central Nervous System (CNS) Lymphoma or microglioma is a disease in which cancer cells are formed in the lymph tissue of brain or spinal cord. This is observed primarily in the patients with very weak immune systems, patients suffering from immonosuppression and AIDS patients. Moreover, this disorder may affect eyes as well called as ocular lymphoma. Patients recently having kidney or other organ transplant are also at a high risk of having CNS lymphoma due to their low count of T-Cells or low level of immunity. The major symptoms of this disease majorly depend on the area affected. However, the major symptoms include headaches, memory problem, drowsiness, seizures, nausea, vomiting, personality changes, throat infection, body weakness and sometimes even hearing loss and double vision. This disease may occur in all age groups; however, mostly noticed in 50+ age group.

There are several diagnosis methods to detect CNS lymphoma; however, treatments are subjected to several clinical trials. The report covers the major diagnosis methods including lumber puncture, pathological analysis of Cerebro-Spinal Fluid (CSF), brain biopsy sampling, Magnetic Resonanace Imaging (MRI), Computed Topography (CT) scan, stereostatic biopsy, and complete blood count. Among all these, MRI scan is most widely used diagnosis method and accounts for larger percent share in the diagnosis market of CNS lymphoma. At later stage of the disease, brain biopsy, tissue biopsy, and spinal tap are the most important tests to make a definite diagnosis. Diagnosis of CNS lymphoma at early stage is difficult and can often be delayed by doctors as well as patients.

CNS Lymphoma Market

The report highlights the prime factors impacting the growth of CNS lymphoma detection and treatment market with detailed analysis on drivers, restraints, and opportunities in the market. The major causes of the disease, its prognosis, and diagnosis are deeply analyzes and their granular level analysis is provided in the report. The report covers various treatments used for nowadays for treating CNS lymphoma. Some of these include radiation therapy, chemotherapy, high dose chemotherapy with stem cell transplant, and targeted therapy. Radiation therapy is considered most successful amongst all; however, is associated with several other complications due to repetitive radiation exposure. Chemotherapy involves usage of high dosage of drugs which may result in to other several side effects. Previously, there were very poor chances of life expectancy for a person suffering from CNS lymphoma; however, due to high technological advantages and types of available treatments these days, the life expectancy is prolonged and patients have opportunity of recovery.

The report offers in depth regional analysis of CNS lymphoma treatment and diagnosis market. The major regions covered in the report include North America, Europe, Asia-Pacific, and Latin America. The geographies with high market revenue are analyzed and the developments are exhaustively tracked for these regions. Among all the regions, Europe is estimated to have high investments in research & development of the treatments and drugs for CNS lymphoma. There is lacks disease awareness among the people in most of the countries in Asia-Pacific region but is expected to have high potential growth for the diagnosis and treatment of CNS lymphoma in next 5 years.

The report gives detailed insights on the competitiveness of the market. The report tracks the key business strategies and developments adopted by the key vendors in this market. Market share analysis of these vendors is also provided under the market entropy section.

Some of the major research centers for the CNS lymphoma include:
Brain & spine Foundation
Royal National Institute for Blind (RNIB)
Carers UK
Macmillan Cancer Support
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Market Overview
2. Executive Summary
3. CNS Lymphoma Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. End-User Profiling
3.2.2. Patent Analysis
3.2.3. Financial Analysis of Top 5 Players
4. CNS Lymphoma Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of Industry
4.4.1. Power of Supplier
4.4.2. Power of Consumer
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. CNS Lymphoma Market-Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product Life Cycle Analysis
5.5. Suppliers & Distributors
6. CNS Lymphoma Market - By Prognosis Type
6.1. Immunocompetent
6.2. AIDS
7. CNS Lymphoma Market - By Type of Diagnosis
7.1. Lumbar Puncture/Pathological Analysis of cerebrospinal fluid (CSF)
7.2. Brain biopsy sampling
7.3. MRI (magnetic resonance imaging)
7.4. CT (computed topograph)Scan
7.5. Stereotactic Biopsy
7.6. Complete Blood Count
7.7. Others
8. CNS Lymphoma Market Market - By Types of Treatments
8.1. Radiation Therapy
8.2. Chemotherapy
8.3. Steroid Therapy
8.4. High-dose chemotherapy with stem cell transplant
8.5. Targeted Therapy
8.6. Others
9. Clinical Information System Market - By Geography
9.1. North America
9.1.1. The U.S.
9.1.2. Canada
9.1.3. Rest of North America
9.2. Europe
9.2.1. The U.K.
9.2.2. Germany
9.2.3. France
9.2.4. Spain
9.2.5. Italy
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. Australia
9.3.5. Rest of APAC
9.4. Latin America
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Mexico
9.4.4. Rest of Latin America
9.5. Rest of the World
9.5.1. The Middle East
9.5.2. Africa
10. CNS Lymphoma Market Entropy
10.1. New Product Launches
10.2. M&As, Collaborations, Partnerships & JVs
11. Company Profiles (Overview, Financials, Products & Services, Recent Developments, Competitors & Customers)
11.1. Brainstrust
11.2. Brain and Spine Foundation
11.3. Headway
11.4. Royal National Institute for the Blind (RNIB)
11.5. Carers UK
11.6. Cancer Research UK
11.7. American Brain Tumor Association
11.8. Leukaemia Foundation
11.9. Macmillan Cancer Support
11.10. Center for Lymphoid Malignancies

"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown